The current Ebola outbreak highlights the potential use of MRNA technology to respond rapidly to viral threats, especially ones we don't have vaccines or treatments for, like the Ebola strain that is emerging in Central Africa. But last year, Health and Human Services terminated $500 million in contracts for cutting edge MRNA vaccine development. and then redirected that funding to 80 year old vaccine technology. Experts have expressed serious concerns that this technology is outdated and inferior and that the way the funding was awarded circumvented the scientific review process. (00:22–00:32)
CLAIM
Asserts that $500 million in MRNA vaccine development contracts were terminated by Health and Human Services.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
